Aprameya EngineeringNSE:APRAMEYA +0.43%41 PEG Ratio is 2.35 as of Jul. 04, 2026, which is 400% above its 10-year median of 0.47. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 41/100. The stock has 6 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Aprameya Engineering ranks worse than 58.45% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Aprameya Engineering's PEG Ratio or its related term are showing as below:
NSE:APRAMEYA'
s PEG Ratio Range Over the Past 10 Years
Min: 0.17 Med: 0.47 Max: 3.62
Current: 2.35
During the past 7 years, Aprameya Engineering's highest PEG Ratio was 3.62. The lowest was 0.17. And the median was 0.47.
NSE:APRAMEYA's PEG Ratio is ranked worse than 58.45% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs NSE:APRAMEYA: 2.35
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Aprameya Engineering (NSE:APRAMEYA) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Aprameya Engineering PEG Ratio Related Terms
Aprameya Engineering PEG Ratio Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: PEG Ratio Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Aprameya Engineering (NSE:APRAMEYA) has a PEG Ratio of 2.35 as of Jul. 04, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Aprameya Engineering and its competitors. This is 400% above median its historical median of 0.47. Over the past decade, Aprameya Engineering's PEG Ratio has ranged from 0.17 to 3.62. According to the industry distribution chart, Aprameya Engineering ranks #121 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 58.5%.
Is Aprameya Engineering's PEG Ratio too high?
Aprameya Engineering's current PEG Ratio of 2.35 is 400% above median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 3.62. The Medical Devices & Instruments industry median PEG Ratio is 2.03. Aprameya Engineering's value of 2.35 is 15.8% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #121 out of 207 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #121 out of 207 companies for PEG Ratio. This places Aprameya Engineering in the lower half of its industry. The industry median PEG Ratio is 2.03. Aprameya Engineering's value of 2.35 is 15.8% above this benchmark. Historically, Aprameya Engineering's own PEG Ratio has ranged from 0.17 to 3.62 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 2.03, Aprameya Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current PEG Ratio of 2.35 is 15.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current PEG Ratio is 2.35, which is 400% above median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current PEG Ratio of 2.35. The current PEG Ratio is 2.35, which is 400% above median its 10-year median of 0.47 and 15.8% above the Medical Devices & Instruments industry median of 2.03. Aprameya Engineering's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current PEG Ratio is 2.35 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
41GF Score
Get the complete analysis for NSE:APRAMEYA
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 